Kinetics of Biomarkers for Therapeutic Assessment in Swiss Mice Infected with a Virulent Trypanosoma cruzi Strain
Pathogens · 2026
DOI: 10.3390/pathogens15010107 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pathogens, 2026. Verfasst von María Fernanda Alves-Rosa und 11 weiteren Autor:innen. Beteiligte Einrichtung: Division of Human Health and Diseases, Instituto de Investigaciones Científicas y Servicios de Alta Tecnología (INDICASAT AIP), Panama 0843, Panama. Hauptthemen laut MEDLINE: Chagas Disease, Trypanosoma cruzi, Biomarkers. Die Arbeit nennt 86 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Secretaría Nacional de Ciencia, Tecnología e Innovación, Secretaría Nacional de Ciencia y Tecnología (SENACYT) of Panama.
Abstract (Originalsprache)
Chagas disease (CD), caused by Trypanosoma cruzi, is a neglected tropical illness affecting 6–8 million people in Latin America. Reaching scholarly consensus on the host response to T. cruzi infection remains a significant challenge, primarily due to substantial heterogeneity in outcomes driven by both the choice of animal model and the infecting parasite’s discrete typing unit (DTU). This variability complicates the evaluation and comparison of new therapeutic compounds against existing drugs, namely benznidazole and nifurtimox. This study provides a comprehensive, kinetic, multifaceted characterization of the acute infection using the highly virulent T. cruzi Y strain (TcII) in outbred Swiss mice. Here, crucial infection parameters are presented, including the optimal infective dose, the parasitemia dynamics, tissue damage markers, hematological profiles, cytokine production (Th1/Th2/Th17/Th22), and molecular parasite identification in target organs (heart, colon, esophagus, spleen, and liver) across the span of the infection. The novelty of this study lies in the kinetic integration of these parameters within a defined model; rather than presenting isolated data points, we demonstrate how the biochemical, physiological, and clinical signs and immunological responses, with the resulting organ involvement, evolve and interact over time. To complete the report, a necropsy evaluation was performed at the end of the acute, fatal infection, and it is presented here. This study fulfills a long-standing recommendation from diverse drug discovery groups for the creation of a definitive reference model to standardize preclinical testing for anti-Chagasic agents.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Human Health and Diseases, Instituto de Investigaciones Científicas y Servicios de Alta Tecnología (INDICASAT AIP), Panama 0843, Panama.
- Sistema Nacional de Investigación (SNI), Secretaría Nacional de Ciencia Tecnología e Innovación (SENACYT), Panama 0843, Panama.
- Facultad de Medicina, Departamento de Microbiología Humana, Universidad de Panamá, Panama 0801, Panama.
- Medical Microspectroscopy Research Group, Department of Experimental Medical Science, Faculty of Medicine, Lund University, 22184 Lund, Sweden.
- Escuela de Biotecnología, Facultad de Ciencias de la Salud, Universidad Latina de Panamá, Panama 0823, Panama.
- Facultad de Ciencias Naturales, Exactas y Tecnología, Departamento de Genética y Biología Molecular, Universidad de Panamá, Panama 0801, Panama.
ORCID-Profile: María Fernanda Alves-Rosa, Doriana Dorta, Alexa Prescilla-Ledezma, Jafeth Carrasco, Michelle G Ng, Adelenis Vega, Melany Morales, Davis Beltran, Rosa De Jesús, Carmenza Spadafora
Förderung
- Secretaría Nacional de Ciencia, Tecnología e Innovación
- Secretaría Nacional de Ciencia y Tecnología (SENACYT) of Panama
Zitieren
APA
Alves-Rosa, M. F., Dorta, D., Prescilla-Ledezma, A., Carrasco, J., Bonner, L., Tamayo, J. J., Ng, M. G., Vega, A., Morales, M., Beltran, D., De Jesús, R., & Spadafora, C. (2026). Kinetics of Biomarkers for Therapeutic Assessment in Swiss Mice Infected with a Virulent Trypanosoma cruzi Strain. Pathogens. https://doi.org/10.3390/pathogens15010107
Vancouver
Alves-Rosa MF, Dorta D, Prescilla-Ledezma A, Carrasco J, Bonner L, Tamayo JJ, et al. Kinetics of Biomarkers for Therapeutic Assessment in Swiss Mice Infected with a Virulent Trypanosoma cruzi Strain. Pathogens. 2026. doi:10.3390/pathogens15010107
BibTeX
@article{AlvesRosa2026,
author = {Alves-Rosa, María Fernanda and Dorta, Doriana and Prescilla-Ledezma, Alexa and Carrasco, Jafeth and Bonner, Leighanne and Tamayo, Jon J and Ng, Michelle G and Vega, Adelenis and Morales, Melany and Beltran, Davis and De Jesús, Rosa and Spadafora, Carmenza},
title = {Kinetics of Biomarkers for Therapeutic Assessment in Swiss Mice Infected with a Virulent Trypanosoma cruzi Strain},
journal = {Pathogens},
year = {2026},
doi = {10.3390/pathogens15010107}
}
EUVIMED